Characteristic | Group | No. | (%) |
---|---|---|---|
Age (year) | Median (range) | 63 (45–76) |  |
≥63 | 43 | (52) | |
<63 | 40 | (48) | |
Gender | Male | 67 | (81) |
Female | 16 | (19) | |
Performance Status (KPS) | ≥80 | 78 | (94) |
70–80 | 5 | (6) | |
Primary tumor location | Cervix+Upper thorax | 6 | (7) |
Middle thorax | 36 | (43) | |
Lower thorax | 41 | (49) | |
Radical surgery | Ivor-Lewis | 48 | (58) |
Sweet | 26 | (31) | |
Stage of primary tumor | I + II | 49 | (59) |
(AJCC 7th edition) | III | 34 | (41) |
Interval to recurrence (month) | Median (range) | 5 (1–59) |  |
>6 | 20 | (24) | |
≤6 | 63 | (76) | |
Lymph node recurrence site | Supraclavicular region | 6 | (7) |
Mediastinal | 50 | (60) | |
Abdominal | 2 | (2) | |
Multiple | 25 | (30) | |
Recurrent lymph node size (cm3) | Median (range) | 5.5 (1.22–123.21) |  |
>5.5 | 41 | (49) | |
≤5.5 | 42 | (51) | |
Number of lymph node recurrence (no.) | Median (range) | 2 (1–6) |  |
Multiple | 64 | (77) | |
Single | 19 | (23) | |
Radiation dose | Median (range) | 60 (50.4–66.2) |  |
≥60Gy | 46 | (55) | |
<60Gy | 37 | (45) | |
Treatments after recurrence | RTa | 41 | (49) |
RT + CTb | 42 | (51) |